We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · June 21, 2021

Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Rates of Renal Function in Anticoagulated Patients With Atrial Fibrillation

Circulation: Cardiovascular Quality and Outcomes

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation: Cardiovascular Quality and Outcomes
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries
Circ Cardiovasc Qual Outcomes 2021 Jun 03;[EPub Ahead of Print], M Rohla, L Pecen, R Cemin, G Patti, JM Siller-Matula, RB Schnabel, K Huber, P Kirchhof, R De Caterina

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading